Biotronik’s Itrevia Heart Failure System Treats First Patients

Biotronik said Tuesday that the first patients have been implanted with its Itrevia HF-T QP cardiac resynchronization defibrillator device.

The system features a closed loop stimulation algorithm that adapts heart rate in response to acute mental stress independent of body movements or respiratory rate, the German devicemaker says.

In a clinical trial, use of the CLS algorithm led to a 75 percent reduction in incidence of orthostatic hypotension compared to an accelerometer, the standard of care in most CRT-D devices that requires a patient to be in motion before increasing heart rate, the company claims.

Biotronik’s Itrevia ICD and CRT-D series for heart failure were also released this year. All cardiac products come with the company’s home monitoring system, which the devicemaker claims has been shown to reduce all-cause mortality by more than 50 percent. — Jason Scott